Linvoseltamab Achieves High Response Rates in Relapsed or Refractory Myeloma

Press/Media

Period	21 May 2024

Media coverage

Title	Linvoseltamab Achieves High Response Rates in Relapsed or Refractory Myeloma
Media name/outlet	The ASCO Post
Country/Territory	United States
Date	21/05/24
URL	ct.moreover.com/?a=53866263034&p=1gw&v=1&x=JEORJ18D7JHyesKgPEEkPg
Persons	Sundar Jagannath